News
Stay informed about the latest developments at Dr. Vince Clinical Research, from expanded capabilities and facility investments to industry insights and company news.
Explore the latest updates below, or contact us to learn how we can support your next study.
Dr. Vince Clinical Research Expands CRO Capabilities as William Lavery, MD, PhD, Earns Board Certification in Obesity Medicine
Milestone enhances DVCR’s ability to conduct increasingly complex obesity and metabolic drug development programs. Overland Park, Kan.; June 3, 2026 (Business…
Dr. Vince Clinical Research Expands Leadership in Renal and Hepatic Clinical Pharmacology Studies
Harry Alcorn, PharmD joins as Senior Vice President of Renal and Hepatic Research to advance scientific and operational expertise. Overland…
Dr. Vince Clinical Research Announces First Dosing in Atopic Dermatitis Patients with Enveda’s First-in-Class Investigational Drug ENV-294
Multi-site trial evaluates the novel anti-inflammatory effects of ENV-294 in adults with moderate to severe atopic dermatitis. Overland Park, Kan.;…
Campus Expansion Marks Dr. Vince Clinical Research’s Investment in People, Infrastructure and Innovation
New administration building opens, reinforcing DVCR’s commitment to operational excellence and a thriving team culture. OVERLAND PARK, Kan.; July 24,…
Dr. Vince Clinical Research Expands Campus with New Administration Building
OVERLAND PARK, Kan.; January 14, 2025 (Business Wire) – Dr. Vince Clinical Research (DVCR), a contract research organization (CRO), announces the expansion of…
Dr. Vince Clinical Research Builds Clinical Laboratory Division
OVERLAND PARK, Kan.; November 12, 2024 (Business Wire) – Dr. Vince Clinical Research (DVCR) is pleased to announce the addition of a cutting-edge…
Dr. Vince Clinical Research Presents Groundbreaking Webinar on Accelerating Clinical & Drug Development Timelines with AI
OVERLAND PARK, Kan.–(BUSINESS WIRE)–Dr. Vince Clinical Research (DVCR), a full-service contract research organization (CRO) specializing in early-phase clinical trials, is…
Dr. Vince Clinical Research Appoints World-Renowned Drug Developer, Clinical Pharmacologist and Neuroscientist Dr. Sheldon Preskorn as Senior VP of Neuroscience
OVERLAND PARK, Kan.—(BUSINESS WIRE)—Dr. Vince Clinical Research (DVCR), a full-service contract research organization (CRO), today announced the appointment of Sheldon…
Dr. Vince Clinical Research Announces First Dosing in a Phase II Study in Patients with Depression
OVERLAND PARK, Kan.—(BUSINESS WIRE)—Dr. Vince Clinical Research (DVCR), a contract research organization specializing in early phase trials, announced the first…
Dr. Vince Clinical Research Launches New Solution for Organ Impairment Studies
OVERLAND PARK, Kan.–(BUSINESS WIRE)–Dr. Vince Clinical Research (DVCR), a full-service Phase I-II contract research organization (CRO) announced a new solution to…